TOFACITNIB TABLET-5GM
Tofacitinib 5 mg is an oral Janus kinase (JAK) inhibitor used to manage moderate to severe autoimmune conditions. By targeting specific pathways in the immune system, Tofacitinib helps reduce inflammation, joint damage, and disease progression, providing patients with improved mobility and quality of life. It is commonly prescribed for conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Benefits:
- Reduces joint pain, stiffness, and swelling.
- Slows progression of joint damage in autoimmune diseases
- Helps control chronic inflammation effectively
- Improves physical function and daily mobility
- Convenient oral dosing for long-term disease management
Indications:
Tofacitinib 5 mg is indicated for:
-
Rheumatoid arthritis in adults with inadequate response to methotrexate
-
Psoriatic arthritis for symptom control and improved joint function
-
Ulcerative colitis to induce and maintain remission in moderate to severe cases
- Other autoimmune conditions as prescribed by a healthcare professional
